Molecular Oncologic Imaging 2791-965X Mersin University 10.71286/moi.1861275 Nuclear Medicine Nükleer Tıp A patient with two congenital anomalies: Poland syndrome and patent urachus. https://orcid.org/0000-0001-7628-7640 Şen Ahmet Necmettin Erbakan University Medicine Faculty, Department of Nuclear Medicine https://orcid.org/0000-0003-3121-5330 Erol Mustafa Necmettin Erbakan University Medicine Faculty, Department of Nuclear Medicine https://orcid.org/0000-0003-0650-0690 Kaya Buğra Necmettin Erbakan University Medicine Faculty, Department of Nuclear Medicine https://orcid.org/0000-0001-5318-0066 Şahin Özlem Necmettin Erbakan University Medicine Faculty, Department of Nuclear Medicine https://orcid.org/0000-0002-4788-4734 Ünüvar Şeyma University Of Health Sciences, Konya City Hospital, Department of Radiology 04 30 2026 6 1 20 22 01 11 2026 04 27 2026 Copyright © 2021, Molecular Oncologic Imaging 2021 Molecular Oncologic Imaging

We present a 56-year-old male patient with Poland syndrome and a patent urachus anomaly who underwent F-18 FDG PET/CT imaging for the evaluation of treatment response in high-grade urothelial bladder carcinoma. The patent urachus can mimic malignancy due to urinary activity, but the development of primary or metastatic tumors in this region is a point to consider. Poland syndrome is a rare syndrome involving thoracic deformities.

 bladder cancer poland syndrome patent urachus This study did not receive any financial support from public, commercial, or non-profit funding agencies. 1. Tafti D, Cecava ND. Poland Syndrome. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30335292. Tafti, D., & Cecava, N. D. (2023). Poland Syndrome(Archived). In StatPearls. StatPearls Publishing. 2. Delay, E., Nachaoui, H., & Frobert, P. (2022). Syndrome de Poland [Poland's syndrome]. Annales de chirurgie plastique et esthetique, 67(5-6), 358–373. https://doi.org/10.1016/j.anplas.2022.07.020 3. Buddha, S., Menias, C. O., & Katabathina, V. S. (2019). Imaging of urachal anomalies. Abdominal radiology (New York), 44(12), 3978–3989. https://doi.org/10.1007/s00261-019-02205-x 4. Briggs, K. B., & Rentea, R. M. (2023). Patent Urachus. In StatPearls. StatPearls Publishing. 5. Kumar, R., Harilal, S., Abdelgawad, M. A., Ghoneim, M. M., Kumar, A., & Mathew, B. (2023). Urachal carcinoma: The journey so far and the road ahead. Pathology, research and practice, 243, 154379. https://doi.org/10.1016/j.prp.2023.154379 6. Stokkel, L. E., Stokkel, M. P. M., Donswijk, M. L., Lahaye, M. J., Bekers, E. M., van Rhijn, B. W. G., & Mertens, L. S. (2021). The Diagnostic Value of FDG-PET/CT for Urachal Cancer. Clinical genitourinary cancer, 19(5), 373–380. https://doi.org/10.1016/j.clgc.2021.03.002 7. Long, N. M., & Smith, C. S. (2011). Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights into imaging, 2(6), 679–698. https://doi.org/10.1007/s13244-010-0062-3